pharma · Advanced Solid Tumor · Chronic Lymphocytic Leukemia
BEONE MEDICINES AUS
BEONE MEDICINES AUS PTY LTD
BEONE MEDICINES AUS is a pharma organization headquartered in Cambridge, USA. Primary therapeutic focus areas include Advanced Solid Tumor, Chronic Lymphocytic Leukemia, Solid Tumor, Adult, Mantle Cell Lymphoma, Previous
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 2010
- Employees
- 3,177
- Programs
- 122
- Drugs
- 63
- Patents
- 0
BGB-A317-290-LTE1
Phase 3 · small molecule · Solid tumors and hamatological malignancies
BGB-A317-290-LTE1 for Solid tumors and hamatological malignancies is a Phase 3 program (small_molecule) at BEONE MEDICINES AUS PTY LTD with 1 ClinicalTrials.gov record(s).
Internal code BGB-A317-290-LTE1
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- BEONE MEDICINES AUS PTY LTD
- Phase
- Phase 3
- Modality
- small_molecule
- Indication
- Solid tumors and hamatological malignancies
- Status
- active
- Trials
- 1